Additional Publications, Commentaries, Editorials and Book Chapters

Czaya B, Faul C.

FGF23 and inflammation – a vicious collation in CKD.

Kidney Int. 2019, in press.

Faul C.

FGF23 effects on the heart – levels, time, source, and context matter.

Kidney Int. 2018, 94: 7-11.

Bhalla V, Agarwal A, Amsler K, Faul C, Hallows KR, McDonough A, Lerman LO, McCormick JA, Miner JH, Tran PV; on behalf of the Biosciences Research Advisory Group (BRAG) of the American Society of Nephrology (ASN).

Advocacy for basic research in nephrology.

ASN Kidney News, 2016, 8: 7.

Faul C, Wolf M.

Hunt for the culprit of cardiovascular injury in kidney disease.

Cardiovasc Res. 2015, 108: 209-11.

Faul C.

The podocyte cytoskeleton – key to a functioning glomerulus in health and disease.

Contrib Nephrol. 2014, 183: 22-53.

Faul C.

FGF23 – neuer Faktor fuer Herzkrankheiten.

Der Nierenpatient 2013, 4: 20-22.

(monthly reports in German language about novel developments in the field of Chronic Kidney Disease in relation to diagnosis, therapy, drug development and research for patients and their relatives and friends; distributed nationwide to nephrologists and patients with kidney disease in Germany)

Trachtman H, Gipson DS, Kaskel F, Ghiggeri GM, Faul C, Gupta V, Fornoni A, Burke GW 3rd, Thomas DB, Barisoni L, Schaefer F, Wei C, Reiser J.

Regarding Maas’s editorial letter on serum suPAR levels.

Kidney Int. 2012, 82: 492.

Faul C.

Cardiorenales Syndrome, die Rolle des Solisten FGF23 im Konzert der LVH.

Nephro-News 2012, 14: 24-27.

(monthly reports on Clinical Nephrology in German language; distributed in Germany, Austria and Switzerland)

Patents

Faul C and Wolf M.

Fibroblast growth factor receptor inhibition for the treatment of disease.

European Patent No. 2723391

Expires on June 14, 2032

Faul C and Yanucil C.

Production and detection of bioactive soluble klotho protein

Provisional application No. 62724886

PCT/US2019/049211; filed August 30, 2019

Faul C and Yanucil C.

Drug screening for FGF23/FGFR4 inhibitors

Provisional application No. 62724895

PCT/US19/49161; filed August 30, 2019